<![CDATA[Alvotech Holdings S.A. 보도자료 - 뉴스와이어]]>https://www.newswire.co.kr/?md=A10&act=article&no=40576>Tue, 05 May 2026 21:41:47 +0900Copyright (c) 2004~2026 Korea Newswire All rights reservedko-KR<![CDATA[Alvotech Clinical Study Results Demonstrate Therapeutic Equivalence between Biosimilar Candidate AVT04 and Reference Product Stelara®]]>https://www.newswire.co.kr/newsRead.php?no=945139Wed, 25 May 2022 16:50:00 +0900<![CDATA[알보텍, 바이오시밀러 후보 물질 ‘AVT04’와 참조 제품 ‘스텔라라’의 치료학적 동등성 입증하는 임상 연구 결과 발표]]>https://www.newswire.co.kr/newsRead.php?no=945140Wed, 25 May 2022 16:50:00 +0900<![CDATA[Alvotech Announces Positive Results from a Pharmacokinetic Similarity Study for AVT04, a Proposed Biosimilar to Stelara®]]>https://www.newswire.co.kr/newsRead.php?no=944659Tue, 17 May 2022 16:40:00 +0900<![CDATA[알보텍, ‘스텔라라’의 바이오시밀러 후보물질인 ‘AVT04’에 대한 긍정적 연구 결과 발표]]>https://www.newswire.co.kr/newsRead.php?no=944660Tue, 17 May 2022 16:40:00 +0900